Thus, it has been shown in several studies that the transcriptomic as well as proteomic diversity introduced by A-to-I editing is exploited by tumor cells to promote cancer progression; for example, more editing events regulated by ADAR1 have been associated with cancer development, primarily due to the more abundant expression of ADAR1 in BC. The gene discussed is ADAR; the disease is neoplasm.